New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
12:15 EDTBAXBaxter spin-off brings 15%-25% potential upside, says Piper Jaffray
Piper Jaffray estimates the potential equity value for Baxter's two businesses around $45B-$50B, which it notes represents upside of between 15%-25% from share current levels. Piper says it remains bullish on Baxter after the company announced the spin-off of its BioScience division. It reiterates an Overweight rating on Baxter with an $82 price target.
News For BAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
10:06 EDTBAXHigh option volume stocks
High option volume stocks: GLOG ACI NGD BEAT BAX TTPH STJ FNF SSTK
August 14, 2015
16:44 EDTBAXThird Point gives quarterly update on stakes
NEW STAKES: Baxter (BAX), T-Mobile (TMUS), Sealed Air (SEE), Devon (DVN), and Perrigo (PRGO). INCREASED STAKES: SunEdison (SUNE), Dow Chemical (DOW), Mohawk (MHK), Yum! Brands (YUM), and IAC/InterActiveCorp (IACI). DECREASED STAKES: Ally Financial (ALLY), Amgen (AMGN), Sensata (ST), Masco (MAS), and Delta (DAL). LIQUIDATED STAKES: Dollar General (DG), McKesson (MCK), Edgewell Personal Care (EPC), Maxim (MXIM), and FleetCor (FLT).
09:01 EDTBAXBaxter, Water Street announce FDA approval for CEFAZOLIN 2 Gram Premix
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use